Cervical Intraepithelial Neoplasia Screening Using Liquid-Based Pap Smear Among Egyptian Women
1 other identifier
observational
984
1 country
1
Brief Summary
This observational study aims to screen Egyptian women aged 25-60 for cervical intraepithelial neoplasia (CIN) using liquid-based Pap smear during routine gynecological visits at Kasr Al-Aini outpatient clinics. Screening is performed through standardized liquid-based cytology to detect early cellular abnormalities that may indicate precancerous changes or cervical cancer. The goal of the study is to identify abnormal cytology at an early stage, improve early detection of cervical cancer, and provide epidemiological data on cervical abnormalities among women attending general gynecological services.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2025
CompletedFirst Submitted
Initial submission to the registry
November 18, 2025
CompletedFirst Posted
Study publicly available on registry
November 26, 2025
CompletedNovember 28, 2025
November 1, 2025
6 months
November 18, 2025
November 25, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Detection of Cervical Cytological Abnormalities
Presence of cytological abnormalities detected using liquid-based cytology (ThinPrep) and interpreted according to the 2014 Bethesda System. Unit of measure: Percentage of participants Outcome measure tool: Liquid-based cytology (LBC) using ThinPrep; Bethesda System classification (ASC-US, LSIL, HSIL, NILM, Unsatisfactory).
At time of screening (single visit)
Secondary Outcomes (2)
Prevalence of Abnormal Cervical Cytology
At time of screening
Correlation Between Participant Characteristics and Abnormal Cytology
At time of screening
Study Arms (1)
Gynecological Screening
Women aged 25-60 attending Kasr Al-Aini outpatient gynecology clinics who undergo liquid-based Pap smear screening for detection of cervical intraepithelial neoplasia.
Interventions
Cervical sample collected using a cervical brush or broom and preserved in liquid fixative solution. Slides prepared using ThinPrep liquid-based cytology and reported according to the 2014 Bethesda System. Used for detection of abnormal cervical cytology including ASC-US, LSIL, HSIL, and NILM.
Eligibility Criteria
Women aged 25-60 attending Kasr Al-Aini outpatient gynecology clinics and undergoing routine cervical screening using liquid-based cytology.
You may qualify if:
- Females aged 25-60
- Attending Kasr Al-Aini outpatient gynecology clinics
- Willing to provide informed consent
You may not qualify if:
- Pregnancy
- Prior hysterectomy
- Existing cervical lesions
- Previous CIN treatment in last 5 years
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kasr Al-Aini Hospital - Cairo University
Cairo, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ahmed M El-Minawi, Professor
Cairo University
- STUDY CHAIR
Yossra Lasheen, Assistant Professor
Cairo University
- STUDY DIRECTOR
Mohamed Aly, Lecturer
Cairo University
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Obstetrics and Gynecology Resident
Study Record Dates
First Submitted
November 18, 2025
First Posted
November 26, 2025
Study Start
September 1, 2024
Primary Completion
March 1, 2025
Study Completion
March 1, 2025
Last Updated
November 28, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share
The study does not plan to share individual participant data. The collected data contain identifiable clinical information and cervical cytology results, and the ethics approval does not permit public release of raw participant-level data. Aggregated data may be available upon reasonable request.